CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,955,000 | -50.0% | 292,292 | -43.3% | 0.12% | -39.9% |
| Q4 2021 | $19,918,000 | -33.1% | 515,489 | -6.5% | 0.20% | -42.5% |
| Q3 2021 | $29,752,000 | +52.0% | 551,065 | -5.9% | 0.35% | +36.3% |
| Q2 2021 | $19,573,000 | +172.4% | 585,311 | +67.8% | 0.26% | +144.3% |
| Q1 2021 | $7,186,000 | +4.3% | 348,840 | -11.3% | 0.11% | -4.5% |
| Q4 2020 | $6,889,000 | +15.6% | 393,215 | -2.1% | 0.11% | -9.0% |
| Q3 2020 | $5,958,000 | – | 401,763 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |